Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01894828
What this trial is testing

Nutritional Supplementation in Patients With no Signs of Malnutrition

Who this might be right for
Primary NeoplasmSecondary NeoplasmAbdominal Neoplasm
MedSource Polska 200
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06663072
What this trial is testing

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Metastatic Pancreatic Neuroendocrine Tumor
University of Chicago 25
Testing effectiveness (Phase 2)Ended earlyNCT04683939
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Who this might be right for
Solid TumorGastric CancerGastroesophageal Junction Adenocarcinoma+5 more
BioNTech SE 13
Testing effectiveness (Phase 2)Study completedNCT00041639
What this trial is testing

Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Gilead Sciences 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Testing effectiveness (Phase 2)UnknownNCT05185869
What this trial is testing

SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 58
Testing effectiveness (Phase 2)Study completedNCT03833661
What this trial is testing

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT00345761
What this trial is testing

Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Chugai Pharmaceutical 64
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Large-scale testing (Phase 3)Active Not RecruitingNCT03803553
What this trial is testing

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Who this might be right for
Metastatic Colon CancerStage III Colon Cancer
Massachusetts General Hospital 400
Early research (Phase 1)Study completedNCT01744353
What this trial is testing

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Who this might be right for
Metastatic Pancreatic Cancer
Brown University 35
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableLooking for participantsNCT05629845
What this trial is testing

Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaVariceal Bleeding
Chinese University of Hong Kong 84
Large-scale testing (Phase 3)Looking for participantsNCT04687631
What this trial is testing

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 508
Large-scale testing (Phase 3)Ended earlyNCT00574275
What this trial is testing

Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm
Sanofi 546
Testing effectiveness (Phase 2)Ended earlyNCT00006001
What this trial is testing

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00034502
What this trial is testing

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Eli Lilly and Company
Early research (Phase 1)Study completedNCT03290937
What this trial is testing

Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT04260139
What this trial is testing

Lymph Node Yield in Colon Cancer Resection Specimens

Who this might be right for
Colon CancerLymph Node Metastases
Bagcilar Training and Research Hospital 50
Next Page